Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Biodegradable particles mimic white blood cells, target inflamed tissue, new study finds

17.12.2003


Scientists have developed biodegradable polymers that can mimic the ability of white blood cells to target inflamed blood vessel walls, according to a new study led by Ohio University researchers. The finding could be the first step in developing drugs that suppress specific sites of inflammation in medical conditions such as arthritis, heart disease and inflammatory bowel disease.



Researchers found that biodegradable beads coated with targeting molecules can travel through the bloodstream and effectively stick to the site of tissue inflammation, a symptom of various diseases, according to the study, which will be published in the Dec. 23 issue of the journal Proceedings of the National Academy of Sciences. Scientists are interested in drugs made from biodegradable polymers because they can be easily prepared, have a long shelf life and can be designed to release specific doses of medication, according to the study.

When the body suffers from a bacterial infection or a wound, the white blood cells, or leukocytes, adhere to the site to treat the problem. But in inflammatory diseases such as arthritis, heart disease or inflammatory bowel disease, leukocytes accumulate in an area where they aren’t needed and cause or progressively worsen the disease.


To address that issue, Ohio University researcher Douglas Goetz and colleagues Justin Hanes of Johns Hopkins University, Kevin Shakesheff of the University of Nottingham in England, Mohammad Kiani of the University of Tennessee Health Science Center and David Kurjiaka of Ohio University have been studying whether biodegradable particles could be used to mimic the activity of leukocytes, traveling to the exact site of the inflammatory disease in the body and delivering treatment. Conventional drugs treat pathological inflammation, but may impact healthy tissue too.

"Can we take a particle and give it the same surface chemistry as the leukocyte and make it go where the leukocyte goes?" asked Goetz, an associate professor of chemical engineering whose research is funded by the National Science Foundation and the Whitaker Foundation.

The new study suggests that in animal models, a biodegradable bead can be coated with targeting molecules and show the same level of adhesion as leukocytes. Shakesheff originally developed the bead, which is made of polylactic acid and polyethylene glycol, two polymers commonly used in other medical applications, Goetz said. This biodegradable particle was 100 times more effective at sticking to the blood vessel wall than other materials tested in previous studies, the engineer said.

The bead degrades and converts to lactic acid, a substance normally found in the body. Goetz and colleagues, using novel polymers developed by Hanes, next will test different polymers – as well as smaller nanoparticles -- that could degrade even faster in the body and offer different drug delivery options, he said. Quick degradation also could help avoid uptake by organs not intended to receive the particles, he said, a possible negative side effect of the process.

The research team also will further examine another interesting finding from the study: The biodegradable particles not only mimic the leukocyte’s ability to stick to tissue, but its tendency to roll along the blood vessel wall. Though Goetz is unsure what impact this finding will have on drug delivery at this point, "it demonstrates how well we can control these particles – not only with selective delivery, but also the type of relationship they have with the vessel wall," he said.

Goetz, who next will study the drug delivery potential for chronic inflammatory conditions, hopes that the combined cell adhesion/drug delivery approach to addressing inflammation-related illnesses will progress in the next 10 years. Other scientists are making progress in creating a targeted drug delivery process to eradicate cancerous tumors, but applying such concepts to inflammatory diseases will call for some fine-tuning, he said. "Applying this to inflammation is a whole different ball game," Goetz said. "A patient probably won’t die from arthritis; it’s a much more subtle problem."

Other collaborators on the study are Harshad Sakhalkar, an Ohio University graduate student in chemical engineering; Milind Dalal, a former Ohio University graduate student in chemical engineering; Aliasger Salem of the University of Nottingham; Ramin Ansari of the University of Tennessee Health Science Center; and Jie Fu of Johns Hopkins University.


Contact: Douglas Goetz, 740-593-1494, goetzd@ohio.edu.

Andrea Gibson | EurekAlert!
Further information:
http://www.ohio.edu/researchnews/

More articles from Studies and Analyses:

nachricht Obstructing the ‘inner eye’
07.07.2017 | Friedrich-Schiller-Universität Jena

nachricht Drone vs. truck deliveries: Which create less carbon pollution?
31.05.2017 | University of Washington

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

Stanford researchers develop a new type of soft, growing robot

21.07.2017 | Power and Electrical Engineering

Vortex photons from electrons in circular motion

21.07.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>